Showing 1 - 8 results of 8 for search 'Yolanda, van der Graaf', query time: 0.04s Refine Results
  1. 1
    Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?

    Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective? by Gijs F. N. Berkelmans, Jacoba P. Greving, Yolanda van der Graaf, Frank L. J. Visseren, Jannick A. N. Dorresteijn

    Published 2020-04-01
    Get full text
    Article
  2. 2
    Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study

    Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study by Anne M. Grool, Yolanda van der Graaf, Theo D. Witkamp, Koen L. Vincken, Willem P. T. M. Mali, Mirjam I. Geerlings

    Published 2011-01-01
    Get full text
    Article
  3. 3
    The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study

    The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study by Frank L J Visseren, Yolanda van der Graaf, Wilko Spiering, Remy H H Bemelmans, Paulus P Blommaert, Annemarie M J Wassink, Blai Coll

    Published 2012-05-01
    Get full text
    Article
  4. 4
    Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension

    Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension by Monique E. A. M. van Kleef, Frank L. J. Visseren, Jan Westerink, Michiel L. Bots, Peter J. Blankestijn, Yolanda van der Graaf, Wilko Spiering

    Published 2020-04-01
    Get full text
    Article
  5. 5
    Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.

    Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease. by Anton P van de Woestijne, Yolanda van der Graaf, Paul I W de Bakker, Folkert W Asselbergs, Wilko Spiering, Frank L J Visseren, SMART Study Group

    Published 2014-01-01
    Get full text
    Article
  6. 6
    Prediction of cardiovascular events by using non-vascular findings on routine chest CT.

    Prediction of cardiovascular events by using non-vascular findings on routine chest CT. by Pim A de Jong, Martijn J A Gondrie, Constantinus F M Buckens, Peter C Jacobs, Willem P T h M Mali, Yolanda van der Graaf, PROVIDI study group

    Published 2011-01-01
    Get full text
    Article
  7. 7
    Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial

    Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled... by Yvo M Smulders, Guy E H M Rutten, Frank L J Visseren, Yolanda van der Graaf, Olga C Damman, Nicole E M Jaspers, Jannick A N Dorresteijn, Corline Brouwers

    Published 2021-07-01
    Get full text
    Article
  8. 8
    Are there gender disparities in symptom presentation or triage of patients with chest discomfort at primary care out-of-hours services? An observational study

    Are there gender disparities in symptom presentation or triage of patients with chest discomfort at primary care out-of-hours services? An observational study by Yolande Appelman, Manon G. van der Meer, Karlijn H.G. Rutten, Yolanda van der Graaf, Hendrik M. Nathoe, Pieter A. Doevendans, Michelle Smit, Emmy Verheij, Anne Botermans, Frans H. Rutten

    Published 2019-11-01
    Get full text
    Article

Search Tools: